Aleksander Kielbik1, Piotr Wawryka1, Dawid Przystupski1, Joanna Rossowska2, Anna Szewczyk3,4, Jolanta Saczko3, Julita Kulbacka3, Agnieszka Chwiłkowska5. 1. Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland. 2. Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Wroclaw, Poland. 3. Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland. 4. Department of Animal Developmental Biology, Institute of Experimental Biology, University of Wroclaw, Wroclaw, Poland. 5. Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland agnieszka.chwilkowska@umed.wroc.pl.
Abstract
BACKGROUND/AIM: There is no satisfactory treatment of glioblastoma multiforme, a highly invasive brain tumor. The aim of this study was to analyze the cytotoxic effects of curcumin (CUR) alone and as a photosensitizer on glioblastoma cells. MATERIALS AND METHODS: The SNB-19 cells where incubated for 2 and 24 h with 5-200 mM of CUR. The cells were radiated with blue light (6 J/cm2) and compared to non-irradiated ones. The effects of treatment were assessed by measuring mitochondrial activity with the MTT method and apoptosis progression by flow cytometry. To investigate CUR uptake, fluorescence imaging of cells was performed. RESULTS: Photosensitization of CUR decreased the EC50 6.3 times when the incubation time was 2 h and over 90% of cells underwent apoptosis. The study of the uptake of CUR showed that during the 2 h, CUR was placed in the entire cytoplasm, and over time, its amount decreased and localized in the subcellular compartments. CONCLUSION: CUR is a promising medicament that can be used as a photosensitizer in photodynamic therapy for glioma treatment. Copyright
BACKGROUND/AIM: There is no satisfactory treatment of glioblastoma multiforme, a highly invasive brain tumor. The aim of this study was to analyze the cytotoxic effects of curcumin (CUR) alone and as a photosensitizer on glioblastoma cells. MATERIALS AND METHODS: The SNB-19 cells where incubated for 2 and 24 h with 5-200 mM of CUR. The cells were radiated with blue light (6 J/cm2) and compared to non-irradiated ones. The effects of treatment were assessed by measuring mitochondrial activity with the MTT method and apoptosis progression by flow cytometry. To investigate CUR uptake, fluorescence imaging of cells was performed. RESULTS: Photosensitization of CUR decreased the EC50 6.3 times when the incubation time was 2 h and over 90% of cells underwent apoptosis. The study of the uptake of CUR showed that during the 2 h, CUR was placed in the entire cytoplasm, and over time, its amount decreased and localized in the subcellular compartments. CONCLUSION:CUR is a promising medicament that can be used as a photosensitizer in photodynamic therapy for glioma treatment. Copyright
Authors: Louis Burt Nabors; Jana Portnow; Mario Ammirati; Henry Brem; Paul Brown; Nicholas Butowski; Marc C Chamberlain; Lisa M DeAngelis; Robert A Fenstermaker; Allan Friedman; Mark R Gilbert; Jona Hattangadi-Gluth; Deneen Hesser; Matthias Holdhoff; Larry Junck; Ronald Lawson; Jay S Loeffler; Paul L Moots; Maciej M Mrugala; Herbert B Newton; Jeffrey J Raizer; Lawrence Recht; Nicole Shonka; Dennis C Shrieve; Allen K Sills; Lode J Swinnen; David Tran; Nam Tran; Frank D Vrionis; Patrick Yung Wen; Nicole R McMillian; Maria Ho Journal: J Natl Compr Canc Netw Date: 2014-11 Impact factor: 11.908
Authors: Mathias P von Beckerath; Johan A Reizenstein; Attila L Berner; Kent W O Nordqvist; Fredrik J Landström; Axel Lennart Löfgren; Claes G Möller Journal: Acta Otolaryngol Date: 2014-05-26 Impact factor: 1.494
Authors: Renata Prandini Adum de Matos; Marilia Freitas Calmon; Camila Fernanda Amantino; Luisa Lina Villa; Fernando Lucas Primo; Antonio Claudio Tedesco; Paula Rahal Journal: Biomed Res Int Date: 2018-01-17 Impact factor: 3.411